In-Vitro Toxicology Testing Market Size- By Method, By End User, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

In-Vitro Toxicology Testing Market Size- By Method, By End User, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033


In- Vitro Toxicology Testing Market Introduction and Overview

According to SPER Market Research, ‘Global In-Vitro Toxicology Testing Market Size- By Method, By End Use, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Global In-Vitro Toxicology Testing Market is estimated to reach USD 34.76 billion by 2033 with a CAGR of 11.05%.

It is well acknowledged that leveraging market opportunities requires the creation of an integrated approach. The growing tendency of outsourcing toxicological assessment services is another factor that is expected to have a significant impact on this market’s growth.

High-throughput and automated testing methods were quickly adopted in response to the pandemic in order to meet the increasing demand and lessen the dependency on manual operations. Increasingly, digital tools have been used for virtual consultations, distant cooperation, and data administration, which has improved research productivity and flexibility.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Method, By End Use, By Technology, By Application
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Abbott, Agilent Technologies, BioIVT, Bio-Rad Laboratories, Inc, Catalent, Inc, Charles River, Creative Bioarray, Evotec, Eurofins Scientific, GE Healthcare, Gentronix, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, SGS SA, Thermo Fisher Scientific Inc.

Global In-Vitro Toxicology Testing Market Segmentation:

By Method:
Based on the Method, Global In-Vitro Toxicology Testing Market is segmented as; Cellular Assay (Live Cells, fixed cells), Biochemical Assay, In-Silico, Ex-vivo.

By Technology:Based on the Technology, Global In-Vitro Toxicology Testing Market is segmented as; Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology.

By Application:Based on the Application, Global In-Vitro Toxicology Testing Market is segmented as; Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Other Applications

By Region:This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.


1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global In-Vitro Toxicology Testing Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global In-Vitro Toxicology Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global In-Vitro Toxicology Testing Market
7. Global In-Vitro Toxicology Testing Market, By Method (USD Million) 2020-2033
7.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2020-2026
7.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2027-2033
7.3. Cellular Assay
7.3.1. Live Cells
7.3.2. Fixed Cells
7.4. Biochemical Assay
7.5. In-Silico
7.6. Ex-vivo
8. Global In-Vitro Toxicology Testing Market, By End Use (USD Million) 2020-2033
8.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2020-2026
8.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2027-2033
8.3. Pharmaceutical Industry
8.4. Cosmetics & Household Products
8.5. Academic Institutes and Research Laboratories
8.6. Diagnostics
8.7. Chemical Industry
8.8. Food Industry
9. Global In-Vitro Toxicology Testing Market, By Technology (USD Million) 2020-2033
9.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2020-2026
9.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2027-2033
9.3. Cell Culture Technology
9.4. High Throughput Technology
9.5. Molecular Imaging
9.6. OMICS Technology
10. Global In-Vitro Toxicology Testing Market, By Application (USD Million) 2020-2033
10.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application, 2020-2026
10.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application 2027-2033
10.3. Systemic Toxicology
10.4. Dermal Toxicity
10.5. Endocrine Disruption
10.6. Ocular Toxicity
10.7. Other Applications
11. Global In-Vitro Toxicology Testing Market Forecast, 2020-2033 (USD Million)
11.1. Global In-Vitro Toxicology Testing Market Size and Market Share
12. Global In-Vitro Toxicology Testing Market, By Region, 2020-2033 (USD Million)
12.1. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2020-2026)
12.2. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2027-2033)
12.3. Asia-Pacific
12.3.1. Australia
12.3.2. China
12.3.3. India
12.3.4. Japan
12.3.5. South Korea
12.3.6. Rest of Asia-Pacific
12.4. Europe
12.4.1. France
12.4.2. Germany
12.4.3. Italy
12.4.4. Spain
12.4.5. United Kingdom
12.4.6. Rest of Europe
12.5. Middle East and Africa
12.5.1. Kingdom of Saudi Arabia
12.5.2. United Arab Emirates
12.5.3. Qatar
12.5.4. South Africa
12.5.5. Egypt
12.5.6. Morocco
12.5.7. Nigeria
12.5.8. Rest of Middle-East and Africa
12.6. North America
12.6.1. Canada
12.6.2. Mexico
12.6.3. United States
12.7. Latin America
12.7.1. Argentina
12.7.2. Brazil
12.7.3. Rest of Latin America
13. Company Profile
13.1. ABBOTT
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. AGILENT TECHNOLOGIES
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. BIO-RAD LABORATORIES, INC
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. CATALENT, INC
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. EUROFINS SCIENTIFIC
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. GE HEALTHCARE
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. MERCK KGAA
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. QUEST DIAGNOSTICS INCORPORATED
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. THERMO FISHER SCIENTIFIC INC
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings